• SPX
  • 6075.11
  • -0.19 %
  • -11.3804
  • DJI
  • 44765.71
  • -0.55 %
  • -248.3281
  • N225
  • 39091.17
  • -0.77 %
  • -304.4297
  • FTSE
  • 8349.27
  • -0 %
  • -0.11
  • IXIC
  • 19700.2586
  • -0.18 %
  • -34.86
Inhibikase Therapeutics, Inc. (IKT) Ownership

Inhibikase Therapeutics, Inc. (IKT) Ownership

NASDAQ Currency in USD Disclaimer

Stock Price

$2.71

-$0.03

(-1.09%)

Day's range
$2.57
Day's range
$2.81
Recent Quarter Total Invested

$50,000

-$2.86 M
Recent Quarter Institutional Ownership Percentage

0.05%

-$16.02
Total Invested of Last Quarter

$2.91 M

Ownership Percentage of Last Quarter

16.07%

Inhibikase Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
HAMILTON LANE ADVISORS LLC 08/08/2023 13,802 $50,000   -83.33% 0.05%
WELLS FARGO & COMPANY/MN 08/15/2023 0 $0   -100.00% 0.00%
NORTHERN TRUST CORP 08/11/2023 0 $0   -100.00% 0.00%
STATE STREET CORP 08/14/2023 0 $0   -100.00% 0.00%
VANGUARD GROUP INC 08/14/2023 0 $0   -100.00% 0.00%
MORGAN STANLEY 08/14/2023 0 $0   -100.00% 0.00%
BLAIR WILLIAM & CO/IL 08/11/2023 0 $0   -100.00% 0.00%
RENAISSANCE TECHNOLOGIES LLC 08/11/2023 0 $0   -100.00% 0.00%
GEODE CAPITAL MANAGEMENT, LLC 08/11/2023 0 $0   -100.00% 0.00%
BANK OF NEW YORK MELLON CORP 08/03/2023 0 $0   -100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 08/14/2023 0 $0   -100.00% 0.00%
VIRTU FINANCIAL LLC 07/27/2023 0 $0   -100.00% 0.00%
REDMOND ASSET MANAGEMENT, LLC 08/09/2023 0 $0   -100.00% 0.00%
ARMISTICE CAPITAL, LLC 08/14/2023 0 $0   -100.00% 0.00%
KOSHINSKI ASSET MANAGEMENT, INC. 07/28/2023 0 $0   -100.00% 0.00%
CCG WEALTH MANAGEMENT, LLC 07/14/2023 0 $0   -100.00% 0.00%
RETIREMENT PLANNING CO OF NEW ENGLAND, INC. 08/11/2023 0 $0   -100.00% 0.00%

Inhibikase Therapeutics, Inc.institutional Ownership - Frequently Asked Questions

  • Who are the largest shareholders of IKT shares?

    During the previous two years, 2 institutional investors and hedge funds held shares of Inhibikase Therapeutics, Inc.. The most heavily invested institutionals were:

    ZEKE CAPITAL ADVISORS, LLC: 93,800

    ACT CAPITAL MANAGEMENT, LLC: 937,500

  • What percentage of Inhibikase Therapeutics, Inc. stock is owned by institutional investors?

    0.05% of Inhibikase Therapeutics, Inc. stock is owned by institutional investors.

  • How much institutional buying is happening at IKT ?

    Institutional investors have bought a total of 1.03 M shares in the last 24 months. This purchase volume represents approximately $2.79 M in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.